Sales and Marketing

Showing 15 posts of 11524 posts found.

ArunSawhneyWebV

Ranbaxy chief executive steps down

August 13, 2010 Medical Communications, Sales and Marketing Daiichi Sankyo, Ranbaxy

The chief executive of Ranbaxy Mr Atul Sobti is to step down after an apparent a rift with the company’s …
Amgen

Amgen’s Vectibix fails late stage trial

August 12, 2010 Research and Development, Sales and Marketing Amgen, Vectibix, head and neck cancer

Amgen’s potential head and neck cancer treatment Vectibix has failed to meet its primary endpoint of improving overall survival in …
Swine flu leaflet

WHO sounds swine flu all clear

August 12, 2010 Sales and Marketing WHO, h1n1, swine flu

The world is no longer in the grips of an H1N1 pandemic and the virus has run its course according …

NICE decides Xolair is not value for money

August 12, 2010 Sales and Marketing NICE, Novartis, Xolair

NICE has refused to back the use of Novartis’ Xolair for young children, saying the asthma drug’s cost brings little …

Genzyme posts loss after inventory write-off

August 12, 2010 Manufacturing and Production, Sales and Marketing Genzyme, manufacturing compliance

Genzyme has had to write off an additional tranche of product that does not meet quality standards, forcing it to …

Two $1 billion dollar acquisition deals go through

August 11, 2010 Sales and Marketing Alcon, M&A, MA, Novartis, Ratiopharm, Teva

Two major acquisition deals mounted by Teva and Novartis are in their final stages as they move to complete potentially …

Quintiles relocates European headquarters

August 11, 2010 Research and Development, Sales and Marketing Quintiles

Contract research organisation and pharma services company Quintiles is moving its European headquarters to Reading in the UK. Previously based …

WHO delists Sanofi-Aventis combo vaccine

August 10, 2010 Manufacturing and Production, Sales and Marketing Sanofi-Aventis, WHO, vaccines

The World Health Organization has dropped a combination vaccine made by Sanofi-Aventis’ subsidiary Shantha Biologics from its list of prequalified …

Elan halts separation plans

August 10, 2010 Manufacturing and Production, Research and Development, Sales and Marketing Elan

Irish drugmaker Elan has postponed plans to separate its business into two publicly-listed companies due to adverse market conditions. Elan …

AstraZeneca reaches $200m Seroquel settlement

August 10, 2010 Sales and Marketing AstraZeneca, Seroquel

AstraZeneca is to pay around £198 million to settle US lawsuits against its troubled anti-psychotic drug Seroquel. The company has …
Boehringer building at night

Generic competition hits Boehringer sales

August 9, 2010 Sales and Marketing 2010 financials, Boehringer, Q2

Boehringer Ingelheim’s sales fell 5% in the first half of 2010, depressed by generic competition and then further dragged down …

Victoza lifts Novo Nordisk

August 9, 2010 Sales and Marketing 2010 financials, Novo Nordisk, Q2

Novo Nordisk has posted a set of healthy results following strong sales from its insulin range and newly launched diabetes …

NICE: the end of an era

August 9, 2010 Sales and Marketing Andrew Lansley, NICE, VBP, government

NICE is undergoing a momentus shift in its role which will see it leave behind the frequent clashes and controversy …

A revolution for the NHS – an opportunity for pharma?

August 9, 2010 Sales and Marketing GlaxoSmithKline, NHS

Healthcare systems across western Europe are currently under renewed pressure and scrutiny, each government preoccupied with finding major cost-savings to …

MSD launches asthma training resources

August 6, 2010 Medical Communications, Sales and Marketing MSD, asthma, medical education, merck sharp and dohme, nurses

A new training resource aimed at helping primary care nurses manage asthma has been launched with funding from Merck Sharp …
The Gateway to Local Adoption Series

Latest content